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. NPMc+ AML patients have high PBX3 and HOXA9 expression. (A-D) The overall survival curves of AML patients with high (n=75) or low (n=75) transcription levels of HOXA3 (A), HOXA5 (B), HOXA7 (C) and MEIS1 (D). The follow-up AML patient survival data was obtained from the TCGA database. The P value was calculated using Kaplan-Meier analyses. (E-F) Detailed information of AML patients with high (n=75) or low (n=75) PBX3 (E) and HOXA9 (F) levels in the TCGA database (see also Figure 1A -B). The orange-filled boxes indicate the NPMc+ AML cells, which mostly harbor high PBX3 and HOXA9 gene expression. (G) A heat map shows the mRNA levels of a cluster of genes expressed differentially (P<0.01, fold change>2) between AML patients with NPMc+ (n=183) and AML patients with WT NPM1 (n=444) from the E-MTAB-3444 database. These top 17 differentiated genes were listed for their significant differentiation between two groups. The selection criterion was based on their P values. The z-score bar measures the color expression intensity. (H) Detailed information on the differentiated genes listed in Figure S1G . 
